Lensar Inc. (LNSR) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Lensar Inc. (LNSR:NASDAQ), powered by AI.

Current Price
$6.18
P/E Ratio
-2.2
Market Cap
74M
Sector
Healthcare
What is the Lensar Inc. stock price forecast?

Lensar Inc. is currently trading at $6.18. View real-time AI analysis on Alpha Lenz.

What is Lensar Inc. insider trading activity?

View the latest insider trading data for Lensar Inc. on Alpha Lenz.

What is Lensar Inc.'s P/E ratio?

Lensar Inc.'s P/E ratio is -2.2.

Lensar Inc.

NASDAQ · LNSR
$6.18+0.46(+8.04%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Lensar Inc.'s future dividend policy...
Alpha Chat Insight

Lensar Inc. trades at a P/E of -2.2 (undervalued) with strong ROE of 324.1%. 3Y revenue CAGR of 18.2% highlights clear growth momentum.

Ask for details

Company Overview

Lensar Inc. is renowned for its advancement in femtosecond laser technology, specifically designed for cataract surgery. As a medical technology company, Lensar focuses predominantly on offering innovative solutions that enhance the precision and effectiveness of cataract surgery procedures. Its flagship product, the Lensar Laser System, is engineered to provide surgeons with superior imaging and laser guidance to perform precise cataract surgeries, thereby improving surgical outcomes and patient safety. Lensar operates at the intersection of healthcare and technology, influencing the ophthalmology sector significantly. By providing state-of-the-art laser systems, the company plays a critical role in advancing surgical standards and patient care in the rapidly growing field of eye health. Headquartered in Orlando, Florida, Lensar continues to contribute to medical technology through continuous research and development, reinforcing its position as a key player in promoting cutting-edge surgical solutions globally.

CEOMr. Nicholas T. Curtis
SectorHealthcare
IndustryMedical Devices
Employees140

Company Statistics

FY 2025

Profile

$73.90MMarket Cap
$58.44MRevenue
0.00Shares Out
140Employees

Margins

46.41%Gross
-16.66%EBITDA
-42.06%Operating
-58.66%Pre-Tax
-58.66%Net

Valuation

-2.16P/E
-2.84P/B
1.26EV/Sales
-6.54EV/EBITDA
-4.96P/FCF

Growth (CAGR)

18.23%Rev 3Yr
17.24%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-49.78%ROA
324.05%ROE
-35.69%ROIC

Financial Health

$12.97MCash & Cash Equivalents
$84.47MNet Debt
-374.53%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Lensar Inc. (ticker: LNSR) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 140 employees. Market cap is $74M.

The current price is $6.18 with a P/E ratio of -2.16x and P/B of -2.84x.

ROE is 324.05% and operating margin is -42.06%. Annual revenue is $58M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Lensar Inc. (LNSR) Stock Forecast 2026 $6.18 — Price, Financials & Analyst Targets | Alpha Lenz